Search details
1.
Dexamethasone potentiates chimeric antigen receptor T cell persistence and function by enhancing IL-7Rα expression.
Mol Ther
; 32(2): 527-539, 2024 Feb 07.
Article
in English
| MEDLINE | ID: mdl-38140726
2.
Health care utilization by long-term survivors of blood or marrow transplantation-A Bone Marrow Transplant Survivor Study report.
Cancer
; 130(5): 803-815, 2024 03 01.
Article
in English
| MEDLINE | ID: mdl-37880912
3.
Body composition and late-occurring chronic health conditions after autologous stem cell transplantation for lymphoma.
Cancer
; 2024 Apr 05.
Article
in English
| MEDLINE | ID: mdl-38579107
4.
Cost-effectiveness of polatuzumab vedotin combined with chemoimmunotherapy in untreated diffuse large B-cell lymphoma.
Blood
; 140(25): 2697-2708, 2022 12 22.
Article
in English
| MEDLINE | ID: mdl-35700381
5.
Response-adapted anti-PD-1-based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE.
Blood
; 139(25): 3605-3616, 2022 06 23.
Article
in English
| MEDLINE | ID: mdl-35316328
6.
Cost-effectiveness of second-line axicabtagene ciloleucel in relapsed refractory diffuse large B-cell lymphoma.
Blood
; 140(19): 2024-2036, 2022 11 10.
Article
in English
| MEDLINE | ID: mdl-35914220
7.
Simultaneous targeting of B-cell malignancies and human immunodeficiency virus with bispecific chimeric antigen receptor T cells.
Haematologica
; 2024 May 23.
Article
in English
| MEDLINE | ID: mdl-38779743
8.
Results from a phase I trial of pembrolizumab plus vorinostat in relapsed/refractory B-cell non-Hodgkin lymphoma.
Haematologica
; 109(2): 533-542, 2024 Feb 01.
Article
in English
| MEDLINE | ID: mdl-37470137
9.
Outcomes following allogeneic hematopoietic cell transplantation relapse in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Am J Hematol
; 2024 May 27.
Article
in English
| MEDLINE | ID: mdl-38800943
10.
Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Am J Hematol
; 2024 May 28.
Article
in English
| MEDLINE | ID: mdl-38804599
11.
Potentially inappropriate medications in geriatric blood or marrow transplantation (BMT) survivors: A BMT Survivor Study report.
Cancer
; 129(3): 473-482, 2023 02 01.
Article
in English
| MEDLINE | ID: mdl-36413424
12.
Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL.
Blood
; 137(4): 471-484, 2021 01 28.
Article
in English
| MEDLINE | ID: mdl-32881995
13.
Feasibility of implementing a supervised telehealth exercise intervention in frail survivors of hematopoietic cell transplantation: a pilot randomized trial.
BMC Cancer
; 23(1): 390, 2023 May 01.
Article
in English
| MEDLINE | ID: mdl-37127595
14.
Association Between Pretreatment Skeletal Muscle and Outcomes After CAR T-Cell Therapy.
J Natl Compr Canc Netw
; 21(4): 373-382.e1, 2023 04.
Article
in English
| MEDLINE | ID: mdl-37015335
15.
Bendamustine lymphodepletion is a well-tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B-cell lymphoma.
Am J Hematol
; 98(11): 1751-1761, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37668287
16.
High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia-like fusions.
Am J Hematol
; 98(6): 848-856, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36880203
17.
Peripheral blood parameter abnormalities precede therapy-related myeloid neoplasms after autologous transplantation for lymphoma.
Cancer
; 128(7): 1392-1401, 2022 04 01.
Article
in English
| MEDLINE | ID: mdl-34962652
18.
Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemia.
Cancer
; 128(3): 529-535, 2022 Feb 01.
Article
in English
| MEDLINE | ID: mdl-34633671
19.
HIV-1 Remission after Allogeneic Hematopoietic-Cell Transplantation.
N Engl J Med
; 390(7): 669-671, 2024 02 15.
Article
in English
| MEDLINE | ID: mdl-38354149
20.
How I treat adults with advanced acute lymphoblastic leukemia eligible for CD19-targeted immunotherapy.
Blood
; 135(11): 804-813, 2020 03 12.
Article
in English
| MEDLINE | ID: mdl-31899793